In the past two years, Johnson & Johnson and its subsidiary Janssen Pharmaceuticals were successfully sued for $257.7 million in Louisiana and $327 million in South Carolina. More recently, J&J has been levied a $1 billion charge in connection with Federal probes into the marketing of Risperdal.
On January 10th 2012, the State of Texas launched its case against J&J, …
Senator Chuck Grassley (R-Iowa) has relentlessly pursued fraud, protectionism, price gouging, and other ethical violations in pharmaceutical and medical device marketing practices. Grassley is the only Republican member of Congress who supports intensified regulation in the health industries. Yet he was an outspoken critic of Obamacare, despite the president’s hopes to recruit him to the cause, and drug companies are …
The Herb Lubalin Study Center at the The Cooper Union is hosting an exhibit on pharmaceuticals in design and marketing, November 1 – December 3, 2011. The exhibit is free and open to the public.
Here is the exhibit description: “The establishment of the pharmaceutical industry, especially in the mid-20th century, played a significant role in the evolution of …
The latest issue of Subjectivity — which focuses on “Neuroscience and subjectivity” — includes a number of interesting articles in the rapidly advancing discussion around neuroscience and society. In their opening Editorial (the only article available without a subscription) guest editors John Cromby, Tim Newton and Simon J Williams argue that:
[T]he neurosciences are likely to continue occupying
…
On March 29, 2011, Nikolas Rose gave a talk here at the University of Chicago entitled “Governing Conduct in the Age of the Brain.” The lecture, which was co-sponsored by the Clinical Ethnography Workshop, the Nicholson Center for British Studies, the Department of Political Science and the Medicine, Body, and Practice Workshop, is available for viewing in …
Recently two important journals have released special issues on closely related topics. A special issue of Biosocieties on “The global health complex” examines the “growing role of pharmaceutical corporations and philanthropic organizations in fight against ‘diseases of the poor’; and a special issue of Medical Anthropology focuses on “Global AIDS Medicines in East African Health Institutions.” …